Drug
Nelarabine
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Neurotoxicity | 60 | 76.0 | 81.0 | signal |
| 2 | Polyneuropathy | 25 | 46.2 | 47.4 | signal |
| 3 | Ataxia | 23 | 42.4 | 43.4 | signal |
| 4 | Pneumocystis Jirovecii Pneumonia | 19 | 41.8 | 42.6 | signal |
| 5 | Bacteraemia | 14 | 26.1 | 26.5 | signal |
| 6 | Hyperbilirubinaemia | 12 | 25.6 | 25.9 | signal |
| 7 | Febrile Neutropenia | 75 | 24.9 | 26.9 | signal |
| 8 | Bone Marrow Failure | 23 | 24.7 | 25.3 | signal |
| 9 | Encephalopathy | 24 | 21.5 | 22.0 | signal |
| 10 | Bladder Disorder | 9 | 19.9 | 20.0 | signal |
| 11 | Malnutrition | 9 | 17.8 | 17.9 | signal |
| 12 | Sensory Disturbance | 13 | 17.7 | 17.9 | signal |
| 13 | Cytopenia | 9 | 16.5 | 16.7 | signal |
| 14 | Posterior Reversible Encephalopathy Syndrome | 7 | 16.1 | 16.3 | signal |
| 15 | Therapy Partial Responder | 11 | 16.0 | 16.2 | signal |
| 16 | Nervous System Disorder | 22 | 15.4 | 15.8 | signal |
| 17 | Septic Shock | 30 | 15.2 | 15.7 | signal |
| 18 | Rhabdomyolysis | 28 | 14.8 | 15.2 | signal |
| 19 | Disseminated Intravascular Coagulation | 9 | 14.0 | 14.1 | signal |
| 20 | Neuropathy Peripheral | 60 | 13.9 | 14.8 | signal |
| 21 | Brain Injury | 6 | 13.1 | 13.2 | signal |
| 22 | Hepatotoxicity | 13 | 12.9 | 13.0 | signal |
| 23 | Hepatic Cytolysis | 7 | 12.6 | 12.7 | signal |
| 24 | Lymphopenia | 8 | 12.5 | 12.6 | signal |
| 25 | Myelosuppression | 19 | 12.3 | 12.5 | signal |
| 26 | Motor Dysfunction | 5 | 10.8 | 10.9 | signal |
| 27 | Altered State Of Consciousness | 10 | 10.2 | 10.3 | signal |
| 28 | Blood Creatine Phosphokinase Increased | 13 | 9.8 | 9.9 | signal |
| 29 | Grand Mal Convulsion | 4 | 9.4 | 9.4 | signal |
| 30 | Acute Myeloid Leukaemia | 6 | 8.5 | 8.5 | signal |
| 31 | Mucosal Inflammation | 10 | 8.4 | 8.5 | signal |
| 32 | Neutrophil Count Decreased | 15 | 8.1 | 8.2 | signal |
| 33 | Neutropenia | 49 | 7.9 | 8.3 | signal |
| 34 | Abasia | 9 | 7.9 | 7.9 | signal |
| 35 | Malignant Neoplasm Progression | 34 | 7.3 | 7.6 | signal |
| 36 | Cytokine Release Syndrome | 6 | 6.9 | 6.9 | signal |
| 37 | Cytomegalovirus Infection | 4 | 5.3 | 5.3 | signal |